@article{3123,
  keywords = {Drug Therapy, Combination, Erythema Nodosum, Humans, Incidence, Leprostatic Agents, leprosy, Leprosy, lepromatous, Models, Molecular, Mycobacterium leprae, Thalidomide, Tumor Necrosis Factor-alpha},
  author = {Teo SK and Resztak K and Scheffler MA and Kook KA and Zeldis JB and Stirling DI and Thomas S},
  title = {Thalidomide in the treatment of leprosy.},
  abstract = {<p>Leprosy is a chronic infection of the skin and nerves caused by Mycobacterium leprae. Erythema nodosum leprosum (ENL) is a reactive state in lepromatous leprosy. Thalidomide has been used to treat ENL since the 1960s. One of its mechanisms of action is anti-inflammatory through selective inhibition of the pro-inflammatory cytokine TNF-alpha produced by monocytes.</p>},
  year = {2002},
  journal = {Microbes and infection},
  volume = {4},
  pages = {1193-202},
  month = {2002 Sep},
  issn = {1286-4579},
  language = {eng},
}